Abstract | PURPOSE: METHODS: MOLT-4 lymphoblastic leukemia cells were stably transfected with a dsRed-tomato virus and were injected subcutaneously into NOD/SCID/γ chain-knockout mice. Tumor growth was monitored with an in vivo imaging system. A pro-IL-16-GFP fusion virus or control GFP only virus was injected into the tumors, and mice were monitored for 1 week. RESULTS: Injection of the pro-IL-16-containing lentivirus inhibited growth of established MOLT-4 tumors in mice. Tumor explants exhibited diminished proliferative capacity. CONCLUSIONS: Our data support the concept that restoration of pro-IL-16 expression in malignant T cells may have therapeutic value.
|
Authors | Jillian Richmond, Michael Finkel, Anna Studwell, Frederic Little, William Cruikshank |
Journal | Journal of cancer research and clinical oncology
(J Cancer Res Clin Oncol)
Vol. 137
Issue 10
Pg. 1581-5
(Oct 2011)
ISSN: 1432-1335 [Electronic] Germany |
PMID | 21818556
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- Interleukin-16
- Protein Precursors
- interleukin 16 precursor
|
Topics |
- Animals
- Cell Line, Tumor
- Genetic Therapy
- Humans
- Interleukin-16
(genetics)
- Lentivirus
(genetics)
- Mice
- Mice, SCID
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
(pathology, therapy)
- Protein Precursors
(genetics)
|